Products

What will AGI do for Aminoglutethimide?

This classification denotes a non-steroidal aromatase inhibitor and anti-adrenal with the molecular formula C13H16N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0O54ZQ14I9, chemically known as 2,6-piperidinedione, 3-(4-aminophenyl)-3-ethyl- but generally known as aminoglutethimide, which bears US NIH Compound Identifier 2145. Aminoglutethimide most often comes in base, phosphate, and racemic forms. European Medicines Agency schedules Aminoglutethimide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05440MIG. The term AMINOGLUTETHIMIDE is an International Non-Proprietary Name. World Health Organization schedules aminoglutethimide in its Anatomical Therapeutic Chemical (ATC) Classification. AMINOGLUTETHIMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aminoglutethimide under HS 29251995 and SITC 51482. As of Q4 2014, AMINOGLUTETHIMIDE remains the US FDA Preferred Term for this commodity. Aminoglutethimide bears US NLM identifiers UMLS ID C0002555 and NCI Concept Code C233. SMILES: O=C1NC(=O)CCC1(CC)C1CCC(N)CC1.

How AGI delivers it

Four ways AGI delivers for Aminoglutethimide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aminoglutethimide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aminoglutethimide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aminoglutethimide connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Impurity Contentmodel
  • Loss On Dryingmodel
  • Melting Pointmodel
  • Particle Size Distributionmodel